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Abstract
CDK1 is a pivotal regulator of resumption of meiosis and meiotic maturation of oocytes. CDC25A/B/C are dual-specificity phosphatases and
activate cyclin-dependent kinases (CDKs). Although CDC25C is not essential for either mitotic or meiotic cell cycle regulation, CDC25B is
essential for CDK1 activation during resumption of meiosis. Cdc25a −/− mice are embryonic lethal and therefore a role for CDC25A in meiosis is
unknown. We report that activation of CDK1 results in a maturation-associated decrease in the amount of CDC25A protein, but not Cdc25amRNA,
such that little CDC25A is present by metaphase I. In addition, expression of exogenous CDC25A overcomes cAMP-mediated maintenance of
meiotic arrest. Microinjection of Gfp-Cdc25a and Gpf-Cdc25b mRNAs constructs reveals that CDC25A is exclusively localized to the nucleus
prior to nuclear envelope breakdown (NEBD). In contrast, CDC25B localizes to cytoplasm in GV-intact oocytes and translocates to the nucleus
shortly before NEBD. Over-expressing GFP-CDC25A, which compensates for the normal maturation-associated decrease in CDC25A, blocks
meiotic maturation at MI. This MI block is characterized by defects in chromosome congression and spindle formation and a transient reduction in
both CDK1 andMAPK activities. Lastly, RNAi-mediated reduction of CDC25A results in fewer oocytes resuming meiosis and reaching MII. These
data demonstrate that CDC25A behaves differently during female meiosis than during mitosis, and moreover, that CDC25A has a function in
resumption of meiosis, MI spindle formation and the MI–MII transition. Thus, both CDC25A and CDC25B are critical for meiotic maturation of
oocytes.
© 2008 Elsevier Inc. All rights reserved.Keywords: Resumption of meiosis; Meiotic maturation; Mouse oocytes; CDC25A; CDC25B; CDK1; MAPK; Spindle formationIntroduction
Meiotic maturation, which involves resumption of meiosis of
prophase I-arrested oocytes, completion of the first meiotic
division and arrest at metaphase II (MII), is controlled by the
activity of the CDK1-cyclin B complex (Dekel, 2005; Kishi-
moto, 2005; Motlik and Kubelka, 1990). CDK1, in addition to
being regulated by its association with a cyclin, is also nega-
tively regulated by phosphorylation on T14 and Y15 that are
located within the ATP-binding loop. The WEE1/MYT1 protein⁎ Corresponding author. Fax: +420 315 639 510.
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doi:10.1016/j.ydbio.2008.02.028kinases mediate this phosphorylation, whereas CDC25 phos-
phatases are responsible for dephosphorylation of T14 and Y15,
which in turn leads to CDK1 activation (Malumbres and
Barbacid, 2005).
CDK1 activity in mouse oocytes is naturally inhibited by
cAMP. cAMP produced by the oocyte (and not derived from the
surrounding cumulus cells that are coupled to the oocyte via gap
junctions) appears essential for maintenance of meiotic arrest
because oocytes, which express adenylate cyclase 3 (AC3)
(Horner et al., 2003), that either lack the G(s)-linked G-protein-
coupled receptor (GPR3) (Freudzon et al., 2005; Mehlmann,
2005; Mehlmann et al., 2004) or in which GPR3 is inhibited by
microinjected anti-GPR3 antibodies (Mehlmann et al., 2002),
resume meiosis within the follicle. A maturation-associated de-
crease in cAMP that precedes NEBD (Schultz et al., 1983) is
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et al., 2004). PKB/AKT kinase, which is important for CDK1
activation and involved in resumption of meiosis (Kalous et al.,
2006), is responsible for PDE3A activation (Han et al., 2006).
cAMP-mediated inhibition of maturation is likely mediated by
PKA phosphorylation of WEE1B, an oocyte-specific member
of WEE1/MYT1 protein kinase family (Han et al., 2005). PKA
also negatively phosphorylates Xenopus CDC25 (Duckworth
et al., 2002) and probably mouse CDC25B (Han and Conti,
2006).
CDC25B phosphatase is essential for CDK1 activation,
because oocytes obtained from Cdc25b −/−mice fail to activate
CDK1 and resume meiosis, but do so following microinjection
of Cdc25bmRNA (Lincoln et al., 2002). Surprisingly, CDC25C
is dispensable for both mitotic and meiotic cell cycles (Chen
et al., 2001). Cdc25a −/− mice exhibit an early embryonic le-
thality, which would be consistent with a critical function for
mitotic cell cycle regulation (Ray et al., 2007). Little is known,
however, about the role of CDC25A in oocyte maturation in
vertebrates. Cdc25amRNA is expressed in mouse oocytes (Wi-
ckramasinghe et al., 1995) but information regarding expression
at the protein level is lacking. Microinjection of Xenopus
Cdc25a mRNA into Xenopus oocytes induces resumption of
meiosis more potently than microinjection of CDC25C mRNA
(Okazaki et al., 1996). Microinjection of bacterially expressed
human CDC25A induces resumption of meiosis of Xenopus
oocytes but the oocytes are arrested at metaphase I-stage and do
not reach metaphase II (Rime et al., 1994).
In somatic cells, CDC25A regulates both G1/S- and G2/M-
associated CDK-activities (Mailand et al., 2002; Molinari et al.,
2000). In late G1, S and G2-phase, CDC25A protein has a very
short half-life (Mailand et al., 2002) as a consequence of CHK1-
mediated phosphorylation during a normal cell cycle (Zhao
et al., 2002). DNA damage or inhibiting DNA replication acti-
vates CHK1 and CHK2 kinases that then lead to rapid degra-
dation of CDC25A, thereby preventing cell cycle progression
(Falck et al., 2001; Mailand et al., 2000; Molinari et al., 2000;
Zhao et al., 2002). In contrast, CDC25A is stabilized by CDK1
phosphorylation on at least two residues, S17 and S115, before
entry to mitosis. This mitotic form of CDC25A is stable even
after ionizing radiation, which induces double-strand DNA
breaks (Mailand et al., 2002). Degradation of CDC25A at ana-
phase and early G1 mediates APC/CCDH1 activation. CDC25A
contains a KEN-box that is essential for degradationmediated by
the APC/C but mutations in the KEN-box mutation do not affect
the stability of CDC25A protein in interphase protein (Donzelli
et al., 2002).
We report here that CDC25A protein is present in fully
grown meiotically competent oocytes (GV-stage). In contrast to
CDC25B, which resides in the cytoplasm, CDC25A is a nuclear
protein. Following NEBD, there is a maturation-associated de-
crease in the amount of CDC25A such that only small amounts
of CDC25A are present in MI and MII eggs. Over-expressing
CDC25A overcomes cAMP-mediated maintenance of meiotic
arrest and RNAi-mediated CDC25A knock-down indicates a
role for CDC25A in both resumption of meiosis and the MI–
MII transition.Materials and methods
Oocyte collection and culture, and RNA microinjection
Mouse ovaries were obtained from 3–4 week-old PMSG-primed (C57BL/6J
X BALB/c) F1 hybrid female mice. Ovaries were transferred to bicarbonate-free
minimal essential medium (Earle salt) at 37 °C and supplemented with 3 mg/ml
of polyvinylalcohol (PVA) and 25 mM HEPES (pH 7.3). To inhibit resumption
of meiosis, the medium contained 0.1 mM 3-isobutyl-1-methyl-xanthine
(IBMX). Oocytes were cultured in M-16 medium (M7292, Sigma Aldrich) at
37.5 °C in 5% CO2 in air.
Oocytes were microinjected with 5 pl of the RNA solution using an MIS-
5000 micromanipulator (Burleigh, Exfo Life Sciences, USA) and PM 2000B4
microinjector (MicroData Instrument, USA). The microinjection medium was
Whitten’s medium supplemented with 10 mM HEPES (pH 7.3) and 0.1 mM
IBMX. Pipets for microinjection were made using P97 Pipette Puller (Sutter
Instrument Company, USA).
In vitro mRNA and dsRNA production for microinjection
pCMV-SPORT6 vector containing mouse full-length Cdc25a (GenBank
accession no. BC046296.1, MGC:66900, IMAGE:6401489), and pYX-ASC
vector containing mouse full-length Cdc25b (GenBank accession no BC057568.1,
MGC:66900, IMAGE:6401489) were purchased from imaGenes GmbH,
Germany (formally RZPD German Resource Center for Genome Research).
Cdc25a and b mRNAs for microinjection were produced by in vitro
transcription using mMESSAGE mMACHINE® T3 Kit (#1348, Ambion). To
generate the template for transcription, full-length mouse Cdc25 a and b cDNAs
were cloned into SpeI site (for N-terminal GFP tags) of the pBluscript-GFP
vector containing a T3-promoter and Xenopus globin 5′UTR, 3′UTR and Kozak
sequences for high mRNA stability and efficient translation initiation,
respectively. This vector was obtained fromMartin Anger, University of Oxford,
UK, and will be described elsewhere. For in vitro transcription, the vectors were
linearized with Asc1. After in vitro transcription, mRNAs were immediately
polyadenylated using the Poly(A) Tailing Kit (#AM1350, Ambion). mRNAs
were purified using RNeasy Mini Kit (#74104, Qiagen). Gfp mRNA for control
microinjection was transcribed from an empty pBluscript-GFP vector.
dsRNAwas produced using MEGAscript® RNAi Kit (#AM1626, Ambion).
A PCR strategy in which the T7 sites were added on both sides of the template
was used to generate template for in vitro transcription. Primers for Cdc25awere
AGGATCCTAATACGACTCACTATAGGGAGAAGCTGCTGGCG-
GACTGTC and ACTCGAGTAATACGACTCACTATAGGGAGACAAACA-
GCCCGCAACGAT, for control Gfp, AGGATCCTAATACGACTAACTA-
TAGGGAGAATGGTGAGCAAGGGCGAGGA and ACTCGAGTAATAC-
GACTCACTATAGGGAGAGCGGCCGCTTTACTTGTACA. The length of
the dsRNA fragment was 653 bp for Cdc25a and 712 bp for Gfp.
Both mRNA and dsRNA, in nuclease-free water (#AM9939, Ambion), were
aliquoted (5 μl) at 500 ng RNA/μl and stored at −80 °C until used for microinjection.
Total RNA isolation and mRNA quantification
Total RNA from 15 or 25 oocytes was isolated using Absolutely RNA®
Microprep Kit (Stratagene) and eluted with 42 μl of elution buffer. External Gfp
mRNA (0.04 pg Gfp mRNA per oocyte) was added to lysed oocytes to serve as
a control for quantifying RNA recovery and normalizing the RT-PCR data to the
exogenously added Gfp mRNA. The eluted total RNA (3 μl) was used in 10 μl
reaction volume using one-step QuantiTect SYBRGreen RT-PCRKit (#204243,
Qiagen). Primers were designed using Beacon Designer software (Premier
Biosoft International, Palo Alto, USA). The following gene-specific primers
were used: Cdc25a primers located at 3′ end of mRNA: AGAACCCTATTGT-
GCCTACTG and TACTCATTGCCGAGCCTATC; Cdc25a primers located at
5′ end of mRNA were purchased (QuantiTect Primer Assay QT01058778,
Qiagen); Gfp primers were TTCAAGATCCGCCACAAC and GACTGGGTG-
CTCAGGTAG. One-step real-time RT-qPCR was done using a Chromo4 Real-
time PCR detection System (Biorad), and passive ROX reference was used for
reaction volume correction. The following one-step real-time qRT-PCR pro-
tocols were used: Cdc25a 3′end: (1) 50 °C 30 min, (2) 95 °C 15 min, (3) 94 °C
15 s, (4) 57 °C 30 s, (5) 72 °C 30 s, (6) 75 °C 3 s, (7) plate reading, (8) go to step
262 P. Solc et al. / Developmental Biology 317 (2008) 260–2693 for 50 additional cycles; Cdc25a 5′end: (1) 50 °C 30 min, (2) 95 °C 15 min,
(3) 94 °C 15 s, (4) 55 °C 30 s, (5) 72 °C 30 s, (6) 72 °C 3 s, (7) plate reading, (8)
go to step 3 for 50 additional cycles;Gfp: (1) 50 °C 30 min, (2) 95 °C 15 min, (3)
94 °C 15 s, (4) 50 °C 30 s, (5) 72 °C 30 s, (6) 72 °C 3 s, (7) plate reading, (8) go
to step 3 for 50 additional cycles. Following quantification of the PCR reaction
product, the Tm of product was determined and the expected size of product was
verified by electrophoresis in a 1% agarose gel. The product sizes and Tm’s
were: Cdc25a 5′end, 124 bp, Tm=79.5 °C; Cdc25a 5′end, 103 bp, Tm=
77.5 °C; and Gfp, 122 bp, Tm=85 °C. Raw data, without smoothening and with
a global minimum base line correction, were imported into Excel, where they
were resized for amplitude normalization. Then data were fit into sigmoid curve
using NCSS200 statistical software (NCSS, Utah, USA) and initial amount of
mRNA was calculated (Liu and Saint, 2002). Cdc25a mRNA expression was
normalized to Gfp mRNA and expressed into graphs in relative arbitrary units.
Immunological methods, antibodies and kinase assays
Standard immunoblot and immunofluorescence methods were used as
previously described (Kalous et al., 2006). For CDC25A immunoblotting,
mouse monoclonal DCS-122 antibody was used (Mailand et al., 2000). For
microtubule visualization using immunofluorescence, mouse monoclonal anti-
acetylated α-tubulin antibody (T7451, Sigma Aldrich) was used. Histone H1
andMAPK assays were performed as previously described (Kalous et al., 2006).
Results
CDC25A protein and mRNA expression during meiotic maturation
In somatic cells, CDC25A protein expression gradually
increases from late G1 and peaks at metaphase but after
anaphase onset CDC25A is degraded because it is a target of theFig. 1. Expression of CDC25A protein and mRNA during meiotic maturation. (a) At th
CDC25A. GV-intact, aNEBD- (2 h), MI- (7 h) and MII- (18 h) stages. aNEBD; 2 h afte
contained 400 oocytes/eggs. (b) Quantification of immunoblots. The experiment wa
dependent decrease in CDC25A protein. The samples were prepared as described in pan
IBMX-free medium. The experiment was done 3 times and quantification is included in
c is included in Supplementary data. (d) Cdc25a mRNA expression in relative arbitra
Cdc25a mRNAwas normalized to exogenous Gfp mRNA, mRNA expression was meAPC/CCDH1 complex (Donzelli et al., 2002; Mailand et al.,
2002). In contrast to somatic cells, CDC25A protein displays a
pronounced decrease shortly after NEBD (Figs. 1a and b) that is
far in advance of anaphase onset, which typically occurs around
8–9 h following initiation of maturation in mouse. By MI the
bulk of CDC25A has been degraded and progression to MII
reveals is accompanied by a further decrease. The apparent
decrease in electrophoretic mobility, which was not always
seen, is likely due to a post-translational modification, e.g.,
phosphorylation, and could mark the protein for degradation.
The maturation-associated decrease in CDC25A protein
requires CDK1 activity (Fig. 1c). Addition of Roscovitine, a
potent CDK1 inhibitor, markedly inhibited the decrease in
CDC25A protein at a time when all control oocytes had under-
gone NEBD (i.e., 2 h after transfer to IBMX-free medium). Mei-
otic maturation triggers degradation of many maternal mRNAs
(Su et al., 2007) and therefore, degradation of Cdc25a mRNA
could underlie the observed decrease in CDC25A protein. Such is
not the case, however, because there was no apparent change in
Cdc25a mRNA during maturation (Fig. 1d), as assessed by
qRT-PCR that analyzed both 5′ and 3′ ends of the mRNA.
Exogenous CDC25A overcomes cAMP-mediated inhibition of
maturation
CDC25B, which can activate CDK1, is essential for initiation
of maturation (Lincoln et al., 2002). Consistent with this findinge indicated times, oocytes were processed for and subjected to immunoblotting for
r transfer to IBMX-free medium, which corresponds to 1 h after NEBD. Each lane
s performed three times and the data are expressed as mean±SEM. (c) CDK1-
el a but Roscovitine (0.025 mM, Rosc) was added after oocytes were transferred to
panel b. Shown is a representative immunoblot; a loading control for panels a and
ry units in GV-intact and MII-arrested eggs. Expression of both 5′ and 3′ ends of
asured in 4 independent experiments. The data are expressed as the mean±SEM.
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ability of IBMX to inhibit maturation (Fig. 2a) with some 79% of
the oocytes undergoing NEBD. CDC25A is a known positive
regulator of both CDK2 (Blomberg and Hoffmann, 1999;
Hoffmann et al., 1994) and CDK1 (Mailand et al., 2002). To
ascertain whether CDC25A can activate CDK1 in mouse
oocytes, we assessed the ability of microinjected GFP-Cdc25a
mRNA to overcome inhibition of maturation by IBMX. Results
of these experiments indicated that over-expression of CDC25A
led to a high incidence of NEBD (Fig. 2a) and activation of
CDK1, as well as MAPK (Figs. 2b and c). Eighteen hours after
Cdc25a mRNA microinjection, 94% of the injected oocytes
underwent NEBD, whereas all of the control Gfp mRNA-
injected oocytes remained at the GV-stage. Noteworthy is that
the level of CDC25A and B expression, as assessed by quan-
tifying GFP fluorescence from the chimeric construct, was
similar (52±10 and 58±18 arbitrary units, respectively). This
finding minimizes the likelihood that higher levels of CDC25A
expression accounted for its ability to induce NEBD when com-
pared to CDC25B. Nevertheless, spindle formation and chromo-
some congression were impaired in oocytes over-expressing
CDC25A (Fig. 2d). These results suggest that CDC25A could
collaborate with CDC25B to initiate and drive maturation.
CDC25A and CDC25B exhibit different localization during
resumption of meiosis
In somatic cells, CDC25A is mainly nuclear (Kallstrom et al.,
2005) whereas CDC25B is mainly cytoplasmic at late G2 when aFig. 2. Exogenous CDC25A overcomes cAMP-mediated GV-stage block. (a) Oocy
indicated Gfp-containing constructs. About 100 oocytes were scored for each grou
microinjection of Gpf-Cdc25a mRNA in IBMX-arrested oocytes (CDC25A, NEB
medium (GFP, GV) and those spontaneously maturing after transfer to IBMX-free m
are expressed as the mean±SEM. (d) Immunocytochemical analysis of spindle form
microinjected with Gpf-Cdc25a mRNA. Red, acetylated α-tubulin; blue, DAPI forportion translocates to the nucleus (Kieffer et al., 2007). We there-
fore addressed CDC25A and CDC25B localization during sponta-
neous resumption of meiosis. GV-stage oocytes in IBMX-sup-
plemented medium were microinjected with either Gfp-Cdc25a or
Gfp-Cdc25b mRNAs and cultured for 60 min to allow protein
expression. When a distinct GFP signal was detected, the oocytes
were washed and transferred to IBMX-free medium to allow them
to resume meiosis. Localization of the fusion proteins was moni-
tored by imaging live cells during resumption of meiosis (Fig. 3).
Prior to NEBD, CDC25A was localized to the nucleus,
whereas CDC25B was essentially cytoplasmic (Fig. 3). Shortly
before NEBD, CDC25A continues to remain nuclear, but a
significant fraction of CDC25B translocates to the GV. Following
NEBD, both GFP-CDC25A and GFP-CDC25B exhibit a diffuse
localization throughout entire oocyte. Consistent with a decline
of the endogenous CDC25A during meiotic maturation (Fig. 1a)
is that GFP-CDC25A signal also decreases following NEBD.
The initial differences in localization suggest that CDC25A and
B are not fully redundant with respect to function, which is
consistent with their functions in somatic cells in which CDC25A
regulates early nuclear events and CDC25B early cytoplasmic
(mainly centrosomal) mitotic events (Cazales et al., 2005;
Dutertre et al., 2004; Lindqvist et al., 2005).
Maturation-associated decrease in CDC25A protein is
essential for the MI–MII transition
The decrease in CDC25A after NEBD at prometaphase I
(Fig. 1a) contrasts with its degradation at anaphase in somatictes were scored for NEBD 18 h following injection of mRNAs encoding the
p. CDK1 (b) and MAPK (c) activities in oocytes resuming meiosis 2 h after
D), and control Gfp mRNA-injected oocytes maintained in IBMX-containing
edium at 2 h (GFP, NEBD). The experiment was conducted 3 times and the data
ation and chromosome congression in defective metaphase I oocytes that were
DNA staining; CDK1.
Fig. 3. CDC25A and CDC25B exhibit different localization during resumption of meiosis. Localization of CDC25A and CDC25B in live oocytes after microinjection
of Gfp-Cdc25a or Gfp-Cdc25bmRNA (150 ng/μl). GV-stage, shortly before (bNEBD) and shortly after (aNEBD) nuclear envelope break down. The experiment was
performed 4 times and 120 oocytes were imaged. Shown are representative examples.
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Mailand et al., 2002). To address the functional significance of
the decrease in CDC25A during maturation, we assessed the
effect of over-expressing CDC25A to overcome the naturally
occurring decrease.
GV-intact oocytes were microinjected with Gfp-Cdc25a or
Gfp-Cdc25b mRNAs. The oocytes were cultured for 60 min
in IBMX-containing medium to inhibit resumption of meiosis
and provide time for protein expression. When a readily detect-
able GFP signal was observed, the oocytes were washed in
IBMX-free medium and then cultured for 18 h and scored for
their ability to reach MII, as assessed by the presence of a polar
body. Control oocytes were microinjected with Gfp mRNA.
Control Gfp and Gfp-Cdc25b mRNA microinjected oocytes
reached MII at 57% or 49%, respectively (Fig. 4a). In contrast,
fewer Gpf-Cdc25a mRNA microinjected oocytes reached MII;
only 10%, 31% and 40% reachedMII after microinjection of 500,250 and 100 ng/μl ofGfp-Cdc25amRNA, respectively. No effect
of over-expression of CDC25A, CDC25B or GFP on NEBD was
observed (data not shown). Similar levels of fluorescence were
observed following injection of 500 ng/μl ofGpf-Cdc25amRNA
and 250 ng/μl Gpf-Cdc25b mRNA (89±26 and 95±26 arbitrary
units, respectively). This finding minimizes the likelihood that
higher levels of CDC25A expression accounted for its ability to
inhibit meiotic progression to MII when compared to CDC25B.
The differences in concentration of the injected mRNAs required
to achieve similar levels of fluorescence likely reflect the
degradation of CDC25A that occurs during maturation.
To ascertain at which stage of meiosis CDC25A over-
expressing oocytes were arrested, injected oocytes were fixed
and stained with an antibody to acetylated-α-tubulin and DAPI
7 h after initiation of maturation by transfer to IBMX-free
medium (Fig. 4b). Control GfpmRNA-injected oocytes reached
MI by this time and possessed well-formed spindles and with
Fig. 4. CDC25A protein degradation is essential for MI–MII transition. (a) Concentration-dependent effect of microinjected Cdc25a mRNA on ability of oocytes to
reach metaphase II by 18 h after transfer to IBMX-free medium. Gfp mRNA-injected oocytes served as the control. Significant differences (pb0.05) in comparison to
GFP controls are marked (*). About 50 oocytes in each group were scored; (b) immunocytochemical analysis of spindle formation and chromosome congression in
control (Gfp mRNA injected) and Cdc25a mRNA-injected oocytes. The cells were processed for immunocytochemistry 7 h after microinjection; in both cases the
injection solution was 250 ng/μl. Red, acetylated α-tubulin; blue, DAPI for DNA staining. About 75 of oocytes were injected and representative images are shown.
CDK1 (c) and MAPK (d) activities at 7 h (MI in control GFP oocytes) and 18 h (MII in control GFP oocytes) after transfer to IBMX-free medium. In all cases, the
oocytes were injected with mRNAs at 250 ng/μl. Significant differences (pb0.05) in comparison to GFP controls at 7 h are marked (*). The experiment was performed
three times and the data are expressed as mean±SEM.
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CDC25A over-expressing oocytes exhibited numerous spindle
defects and problems with chromosome congression. These
perturbations were not observed in CDC25B over-expressing
oocytes that were indistinguishable from GFP over-expressing
oocytes (data not shown).
Because CDC25A dephosphorylates not only CDKs but also
MAPK (Wang et al., 2005), we assayed both CDK1 and MAPK
activities in oocytes to explore whether MI-arrest of CDC25A
over-expressing oocytes is associated with misregulation of
these kinase activities. At 7 h after transfer to IBMX-free me-
dium, when control oocytes (Gfp or Gfp-Cdc25b mRNA inject-
ed) were in MI (Fig. 4b), both CDK1 and MAPK activities were
slightly but significantly reduced in Gfp-Cdc25a mRNA-
injected oocytes when compared to controls (Figs. 4c and d).
This difference was not observed at 18 h, when control oocytes
reached MII and CDC25A over-expressing oocytes were ar-
rested still in meiosis I (Figs. 4c and d).
CDC25A is involved in both resumption of meiosis and MI–MII
transition
The results described above suggest that degradation of
CDC25A protein is required for the MI–MII transition. The
experiments, however, do not address a role, if any, for CDC25Ain resumption of meiosis, which clearly requires CDC25B (Lin-
coln et al., 2002). The absence of oocyte-specific conditional
KO mice for Cdc25a and the early embryonic lethality of
Cdc25a null mice preclude assessing such a role for CDC25A.
To circumvent this problem, we used RNAi to decrease the
amount of oocyte CDC25A protein.
Oocytes were microinjected with long dsRNA and cultured
in IBMX-containing medium for 24 h, which was sufficient to
observe a 90% decrease in Cdc25a mRNA (Fig. 5a); essentially
no degradation of Cdc25a mRNA was observed when oocytes
were injected with long Gfp dsRNA. In addition, the long
Cdc25a dsRNAwas designed such that there was no region of
homology in Cdc25b mRNA that was greater than 11 nuc-
leotides. Further evidence for targeting specificity is that this
approach can target specifically single family members (Ma
et al., 2006; Yu et al., 2004). Following transfer to IBMX-free
medium, the oocytes were cultured for 18 h and then scored for
maturation (Fig. 5b). Compared to control injected oocytes in
which only 16% failed to resume meiosis as evidenced by
NEBD, 36% of oocytes injected with long Cdc25a dsRNA
failed to resume meiosis. In addition, of those oocytes that did
resume meiosis, only 10% reached MII, in contrast to 45% of
their control injected counterparts.
To characterize further the MI arrest of oocytes injected with
long Cdc25a dsRNA, the oocytes were fixed and stained with
Fig. 5. CDC25A is involved in resumption of meiosis and MI–MII transition.
(a) Effectiveness of RNAi-mediated knock-down of Cdc25a mRNA at 24 h
in IBMX-supplemented medium after microinjection of long dsRNA Gfp
RNAi (control) or long Cdc25a RNA. The experiment was performed 4 times
and the data are expressed as the mean±SEM. (b) Meiotic maturation
of control (GFP RNAi) and CDC25A RNAi oocytes scored 18 h after trans-
fer to IBMX-free medium; ∼100 oocytes for each group were scored. (c)
Immunocytochemical analysis of spindle formation and chromosome
congression in GFP RNAi (control) and CDC25A RNAi oocytes at 7 h
after transfer to IBMX-free medium. Red, acetylated α-tubulin; blue, DAPI
for DNA staining. About 80 oocytes were injected and representative images
are shown.
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transfer to IBMX-free medium (Fig. 5c). Control oocytes (Gfp
RNAi) exhibited normal MI spindles formation, where oocytes
injected with long Cdc25a dsRNA exhibited two main pheno-
types. Approximately half of the oocytes had normal MI spindlewith chromosomes aligned at the equatorial plate. The other half
displayed defects with spindle formation and/or chromosomal
congression.
Discussion
The early embryonic lethality of Cdc25a null embryos (Ray
et al., 2007), coupled with the absence of a conditional, oocyte-
specific Cdc25a knockout has precluded to date assessing the
function of CDC25A during early development. Using comple-
mentary approaches of over-expressing and ablating CDC25A,
we describe here the first evidence for a role of CDC25A in
meiotic maturation.
Oocytes are arrested in the first meiotic prophase, which
resembles arrest at the G2/M transition in the cell cycle. The
presence of CDC25A in oocytes is consistent with accumulation
of CDC25A as somatic cells enter M phase. In oocytes,
CDC25B is essential for resumption of meiosis (Lincoln et al.,
2002) and we show that over-expressing CDC25A overcomes
IBMX-inhibition of oocyte maturation. In somatic cells
CDC25A and B collaborate in mitotic events (Lindqvist et al.,
2005), and over-expressing CDC25A induces mitotic events
such as chromosome condensation (Mailand et al., 2000; Moli-
nari et al., 2000). Thus, a competence of CDC25A and B to
induce mitosis entry appears also conserved in meiosis entry
(resumption of meiosis).
CDC25A degradation, which occurs in the absence of any
apparent decrease in Cdc25a mRNA, is apparent within 1 h
following nuclear envelope breakdown and therefore degrada-
tion precedes MI by several hours. In addition, there is little, if
any, degradation of CDC25B during this early time. CDC25A
degradation occurs much later in somatic cells and follows the
metaphase to anaphase transition (Donzelli et al., 2002).
CDC25B is also degraded in somatic cells after sister chromatid
separation (Kieffer et al., 2007).
A functional APC/CCDH1 present in prometaphase oocytes
(Marangos et al., 2007; Reis et al., 2007) may be responsible
for the early degradation of CDC25A. In mouse oocytes,
APC/CCDH1 is required for chromosome congression and
targets destruction of CDC20, the other APC/C activator,
thereby ensuring that CDC20 re-synthesis is required for
meiotic progression. The switch from APC/CCDH1 to
APC/CCDC20 is controlled by increased CDK1 activity and
CDH1 loss (Reis et al., 2007). SCF/βTrCP, which mediates
CDC25A degradation in interphase somatic cells (Donzelli et
al., 2002), promotes degradation of EMI1 (early mitotic
inhibitor 1) that inhibits the APC/C; EMI1 degradation is
required for meiotic progression (Marangos et al., 2007). Both
the APC/CCDH1 and SCF/βTrCP E3-ubiquitin ligases operate in
prometaphase I oocytes (Marangos et al., 2007; Reis et al.,
2007) but which, if any, of them is involved in CDC25A
destruction in mouse oocytes is unresolved. It also should be
noted that, in Xenopus, CDC25A protein is absent in
unfertilized eggs and its synthesis begins within 30 min of
fertilization (Kim et al., 1999). The virtual absence of CDC25A
in MII mouse eggs raises the interesting question when and how
CDC25A accumulates following fertilization.
267P. Solc et al. / Developmental Biology 317 (2008) 260–269The maturation-associated decrease in CDC25A requires
CDK1 activity because inhibiting CDK1 with Roscovitine pre-
vents the decrease. This requirement for CDK1 for rapid
CDC25A degradation stands in stark contrast to CDK1-
mediated phosphorylation of CDC25A leading to its stability
prior mitosis. In somatic cells, CDK1-dependent phosphory-
lation of CDC25A stabilizes CDC25A against activity of
SCF/βTrCP, but not APC/CCDH1 (Mailand et al., 2002), which
normally targets CDC25A during anaphase despite persisting
CDK1 phosphorylation. As discussed above, APC/CCDH1 is a
good candidate for the E3 ubiquitin ligase that targets CDC25A
in prometaphase I oocytes. Moreover, because EMI1 destruc-
tion initiates immediately after GVBD (Marangos et al., 2007),
EMI1 activity presumably continues to inhibit APC/CCDH1
following transferring oocytes from IBMX-supplemented
medium into roscovitin-supplemented medium.
Over-expressing CDC25B overcomes IBMX-mediated
meiotic arrest, a finding consistent with the essential role of
CDC25B for resumption of meiosis (Lincoln et al., 2002).
Likewise, over-expressing CDC25A also induced resumption of
meiosis. This effect cannot be ascribed to expressing higher
amounts of CDC25A than CDC25B and thereby dephosphory-
lating inappropriate substrates, because similar levels of expres-
sion were observed as assayed by measuring GFP fluorescence
from the chimeric proteins. This finding provides the first
evidence that CDC25A plays a role in oocyte maturation.
Although expressing CDC25A induces nuclear envelope
breakdown in IBMX-arrested oocytes, entry intoMI is abnormal
and characterized by abnormal spindle formation and chromo-
some congression, with no apparent sign of exit from MI. A
similar observation was made when CDC25B was over-ex-
pressed (data not shown). The inability of oocytes expressing
either CDC25A or CDC25B to reach MII is probably a conse-
quence of IBMX maintaining high concentrations of cAMP in
these oocytes. Consistent with this interpretation is that injection
ofCdc25bmRNA into Cdc25b null oocytes initiates resumption
of meiosis, with oocytes emitting a polar body and arresting at
MII with a normal spindle and congressed chromosomes in
control IBMX-free medium (Lincoln et al., 2002).
CDC25A and CDC25B display different temporal and spa-
tial patterns of localization. We find that CDC25A is almost
exclusively nuclear in GV-intact oocytes until NEBD occurs. In
contrast, CDC25B is essentially cytoplasmic and translocates to
the GV just prior to nuclear envelope breakdown. A similar
situation was observed for cyclin B that undergoes nuclear
translocation just before NEBD (Reis et al., 2006). Previous
reports on cell cycle-dependent localization of CDC25B in
somatic cells were controversial (Baldin et al., 2002, 2003;
Davezac et al., 2000; Giles et al., 2003; Uchida et al., 2004a,b;
Woo et al., 1999), but the recent results using time-lapse video
microscopy of YFP-CDC25B expressed under control of the
mouse minimal CDC25B promoter show translocation of cyto-
plasmic CDC25B into nucleus during the G2-M transition
(Kieffer et al., 2007). In human somatic cells, cytoplasmic
localization of CDC25B1 is due to its association with either
14-3-3beta or 14-3-3epsilon. This association requires S309 of
CDC25B1; S309 resides within a putative 14-3-3 bindingconsensus sequence and is sufficient for cytoplasmic retention
(Uchida et al., 2004a). Whether S309 plays a similar role in
cytoplasmic localization of CDC25B in oocytes and whether its
phosphorylation regulates CDC25B translocation into the
nucleus shortly before GVBD will be the subject of future
studies.
The differences in localization of the two phosphatases
suggest that they have different substrates and non-redundant
functions. Consistent with this proposal is that over-expression
of CDC25A, but not CDC25B, inhibits meiotic progression to
MII when oocytes are transferred to IBMX-free medium. The
oocytes arrest at MI with an abnormal spindle and poorly con-
gressed chromosomes. As described above, the difference in the
effects of over-expressing CDC25A and CDC25B cannot be
attributed to differences in expression. These results also indi-
cate that CDC25A degradation is essential for the MI–MII
transition. The rationale for conducting the experiment was that
by over-expressing CDC25A that even though the endogenous
and exogenous proteins would be degraded following nuclear
envelope breakdown, the amount CDC25A activity would
remain above a threshold. Interestingly, in these experiments,
activation of CDK1 and MAPK displayed a transient lag when
compared to the increase in these activities following expres-
sion of CDC25B. CDC25A has many non-CDK substrates,
including components of the MAPK pathway (Kar et al., 2002;
Nemoto et al., 2004; Wang et al., 2005; Xia et al., 1999), and the
small transient decrease of MAPK activity (Fig. 4d) may be an
outcome of over-expressing CDC25A. The small transient
decrease in CDK1 activity in these MI arrested oocytes may be
significant, because in yeast and human, a slight decrease of
CDK1 activity does not prevent metaphase spindle formation,
but blocks the metaphase-anaphase transition (Lindqvist et al.,
2007; Rudner et al., 2000).
Reducing the amount of CDC25A by RNAi prior to
resumption of meiosis reveals a role for CDC25A not only in
meiotic progression to MII but also in resumption of meiosis. Of
those oocytes that resume meiosis, half of the MI-arrested
oocytes exhibited an abnormal spindle. Thus, even though the
maturation-associated degradation of CDC25A results in MI
eggs containing very low amounts of CDC25A, these small
amounts nevertheless appear critical for MI spindle formation
and the MI–MII transition. It may seem paradoxical that
CDC25A is required not only for initiation of maturation but
that it must be degraded for a successful MI–MII transition. In
fact, a similar situation is observed for EMI1, which has to be
degraded during meiotic maturation via βTrCF-SCF but is still
required for the MI–MII transition (Marangos et al., 2007). A
possible resolution to this paradox couples the known role of
CDC25A in CDK1 activation with two potentially separate and
later functions. The decrease in CDC25A activity – CDC25A
has a broad substrate spectrum – could modulate the time
course and magnitude of MAPK activation after NEBD (Kar
et al., 2002; Nemoto et al., 2004; Wang et al., 2005; Xia et al.,
1999). In addition, CDC25A probably dephosphorylates other
key substrates during/after NEBD that are required for a
successful MI–MII transition and this dephosphorylation is not
compensated by either the remaining CDC25B or C.
268 P. Solc et al. / Developmental Biology 317 (2008) 260–269In summary, the results described here provide the first
evidence for a critical role for CDC25A in both resumption and
completion of meiosis during oocyte maturation. The functional
inter-relationships in these processes between CDC25A and
CDC25B remain to be resolved.
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